Adherex Technologies
ADHEREX REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS
Adherex Announces Change of Auditor
2009 ASCO Poster: ADH-1
200
KB
WRAL.com: Video on ADH-1 and ILI Melphalan in Melanoma
Adherex Technologies Inc.
A
team of experts
dedicated to identifying, developing and commercializing novel cancer therapeutics
A diversified portfolio of innovative cancer compounds in
preclinical
and clinical development
Three products
in advanced development, each representing a major therapeutic and commercial opportunity
Adherex is focused on developing solutions to unmet needs in cancer
Long-term
complications
Treatment resistance
and
debilitating side effects
Lack of
efficacy
About Us
Product Candidates
Preclinical Pipeline
Collaborations
Partnering
Press Releases
Events
Publications & Patents
Careers
Contact Us
© 2009 Adherex Technologies Inc.
Site Map
|
Internet Disclaimer Statement
site by
webslingerz